IDEAYA Biosciences

About:

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Website: http://www.ideayabio.com/

Top Investors: Alexandria Venture Investments, Google Ventures, Perceptive Advisors, Biotechnology Value Fund, Alexandria Real Estate Equities

Description:

IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.

Total Funding Amount:

$694M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)ideayabio.com

Founders:

Jeffrey Hager, Yujiro S. Hata

Number of Employees:

101-250

Last Funding Date:

2024-07-09

IPO Status:

Public

© 2025 bioDAO.ai